Furthermore, we found that MMP16 gene was the direct target for miR-33a in CFs, and that miR-33a promoted cardiac fibrosis via the p38 MAPK signaling pathway. The gene discussed is MMP16; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.